Pituitary adenomas caused by AIP mutations are of great clinical relevance as they are difficult to treat due to large tumor size and high hormonal secretion levels; additionally, AIP mutations confer relative resistance to first-generation somatostatin analogs [11]. The gene discussed is AIP; the disease is neoplasm.